Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Found 21 COAs referencing this lot from 1 vendor.
Aggregated across 21 COAs for this batch
Tested by: Vanguard Laboratory
| Vendor | Peptide | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Peptidology | Glutathione | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | |
| Peptidology | Survodutide | Vanguard Laboratory | 99.80% | LAL |
| — |
| Peptidology | KLOW | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — |
| Peptidology | Pinealon | Vanguard Laboratory | 99.15% | LALUSP<71>HM | 2026-03-25 |
| Peptidology | FOXO4-DRI | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-25 |
| Peptidology | Gonadorelin | Vanguard Laboratory | 99.16% | LALUSP<71>HM | 2026-03-23 |
| Peptidology | Tesamorelin/Ipamorelin | Vanguard Laboratory | 99.34% | LALUSP<71>HM | 2026-03-23 |
| Peptidology | Ipamorelin | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-09 |
| Peptidology | AOD-9604 | Vanguard Laboratory | 99.03% | MSLALUSP<71>HM | 2026-02-24 |
| Peptidology | GHK-Cu | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-19 |
| Peptidology | GLOW | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-19 |
| Peptidology | Livagen | Vanguard Laboratory | 99.05% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Cardiogen | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Pancragen | Vanguard Laboratory | 99.02% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Cortagen | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Vesugen | Vanguard Laboratory | 99.53% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Vilon | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-13 |
| Peptidology | Cartalax | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-12 |
| Peptidology | Semax/Selank | Vanguard Laboratory | 99.08% | LALUSP<71>HM | 2026-02-04 |
| Peptidology | Selank | Vanguard Laboratory | 99.02% | LALUSP<71>HM | 2026-02-04 |
| Peptidology | MOTS-C | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-01-30 |